Olivier Guitard

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Part of Sartorius AG, Sartorius Stedim Biotech GmbH is a company based in Goettingen, Germany. The CEOs are Helge Henning, Michaela Pischke. The German company was founded in 2007.

Filtration Technology Corp. manufactures oil and gas field machinery. The firm offers liquid filters for bag housings, including bag filters, pleated bag filters, and max-out conversion systems; liquid filters for cartridge housings, such as cartridge filters, pleated cartridge filters, and alternative replacement filters; and hydrocarbon removal filters, oil/water separation filter systems, and wastewater cleanup systems. It also provides technical services and support, and test and analysis services. The company was founded in 1987 and is headquartered in Houston, TX.

Part of Sartorius AG, Sartorius Stedim Systems GmbH is a German company that offers single-use convenience and stainless-steel performance with the GMP ready Biostat STR® Microbial fermenter equipped with Biobrain®. The company is based in Guxhagen, Germany. The CEOs are Ariane Rindlisbacher, Jens Karl. The company was founded in 1988.

Part of Recipharm AB, Wasserburger Arzneimittelwerk GmbH is a German company that manufactures injectable pharmaceuticals. The company is based in Wasserburg am Inn, Germany. The company was founded in 1989. The CEO is Michael Isele. Wasserburger Arzneimittelwerk was acquired by Recipharm AB from Hospira, Inc. on January 31, 2010.

Part of Sartorius AG, Sartorius Stedim Aseptics SAS is a French company that provides engineering services. The company is based in Lourdes, France. The company was founded in 1994. Benedicte Vonsensey has been the CEO of the company since 2017.

Part of Sartorius AG, Sartorius Stedim BioOutsource Ltd. is a British company that provides contract testing services of biologic drugs and vaccines. The company is based in Glasgow, UK. The company was founded in 2007. The CEO is Hugo de Wit. Sartorius Stedim BioOutsource was acquired by Sartorius Stedim Biotech SA on April 17, 2015.

Part of Sartorius AG, Sartorius Korea Biotech Co., Ltd. is a South Korean company that provides engineering services. The company is based in Seongnam, South Korea. The company was founded in 2005. Duk-Sang Kim has been the CEO of the company since 2005.

Part of Sartorius AG, Albumedix Ltd. is a British science-driven company and recognized leader of albumin-enabled solutions. The company, based in Nottingham, UK, was founded in 1984 with a mission to empower excellence. Albumedix has supported its life-science partners in delivering safe doses of clinical and marketed therapeutics. The company's solutions include the world's only USP-NF compliant recombinant human albumin, client-centric development and compliance services, and drug-enhancing technologies. By challenging the status quo and striving for more, Albumedix enables the development and commercialization of advanced therapies and next-generation biopharmaceuticals. Albumedix is the world leader in recombinant human albumin and has developed a portfolio of products known as Recombumin®. Founded in 1973, the CEO of Albumedix is Jonas S. Moller. The company was acquired by Sartorius Stedim Biotech SA on September 30, 2022, for $500.47 million.

Part of Sartorius AG, Sartorius Stedim North America Holding GmbH provides financial services. The company is based in Goettingen, Germany. The CEO of the German company is Uwe Becker.

Part of Sartorius AG, Sartorius Xell GmbH is a German company that specializes in providing solutions tailored to the specific requirements of cell lines, allowing them to achieve optimal product yields. The company, founded in 2009, is based in Schloß Holte-Stukenbrock, Germany. Xell's expertise lies in developing customized production processes, including cell culture media, feeds, and medical products. The company's team of highly skilled and motivated employees, with diverse scientific backgrounds, emphasizes a strong focus on technology and innovation. Sartorius Xell was acquired by Sartorius Stedim Biotech SA on July 29, 2021.